Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vahan Papazian is active.

Publication


Featured researches published by Vahan Papazian.


Journal of Labelled Compounds and Radiopharmaceuticals | 2000

Synthesis of [123I]N' N'-dimethyl-6-methyl-(4'-iodophenyl)imidazo[1,2-a]pyridine-3-acetamide for the study of Peripheral Benzodiazepine receptors using SPECT

Andrew Katsifis; Filomena Mattner; Zhianko Zhang; Branko Dikic; Vahan Papazian

The [123I]labelled imidazo[1,2-a]pyridine [123I]ioddozolpidem 4 was found to exhibit preferential activity towards Peripheral rather than Central Benzodiazepine receptors in vivo and was synthesised for the potential study of the Peripheral Benzodiazepine Receptors (PBR) using SPECT. [123I]Iodozolpidem was prepared from the corresponding tributyl tin precursor by iododestannylation with Na[123I] in the presence of peracetic acid or chloramine-T. Purification by semipreparative C-18 RP HPLC gave the product in radiochemical yields of 60–85%. The product was obtained in >97% chemical and radiochemical purity with a specific activity >80 GBq/μmol. Copyright


Radiochimica Acta | 2000

Synthesis of substituted [123I]imidazo[1,2-α]pyridines as potential probes for the study of the peripheral benzodiazepine receptors using SPECT

Andrew Katsifis; Filomena Mattner; Branko Dikic; Vahan Papazian

The imidazo[1,2-α]pyridines [N,N´-dimethyl-6-chloro-(4´zf-iodophenyl)imidazo[1,2-α]pyridine-3-acetamide 1, [N,N´l-6-chloro-(4´-iodophenyl)imidazo[1,2-α]pyridine-3-acetamide 2, and [N-methyl-6-chloro-(4´-iodophenyl)imidazo[1,2-α]pyridine-3-acetamide 3, are high affinity and selective ligands for the Peripheral Benzodiazepine Receptors (PBR). The [123I]1-3 labelled analogues of these compounds were subsequently synthesised for the potential study of the PBR in vivo using SPECT. Radioiodination was achieved by iododestannylation reactions of the corresponding tributyl tin precursors with Na[123I] in the presence of peracetic acid, chloramine-T or Iodogen. Purification of the crude product was achieved by semipreparative C-18 RP HPLC to give the products in radiochemical yields of 40-85%. The products were obtained in >97% chemical and radiochemical purity and with specific activities >80 GBq/μmol.


Nuclear Medicine and Biology | 2003

Synthesis and evaluation of iodine-123 labelled tricyclic tropanes as radioligands for the serotonin transporter

Mitchell Quinlivan; Filomena Mattner; Vahan Papazian; Jia Zhou; Andrew Katsifis; Patrick Emond; Sylvie Chalon; Alan P. Kozikowski; Denis Guilloteau; Michael Kassiou

The tricyclic tropane analogues (1S,3S,6R,10S)-(Z)-10-(benzoyloxymethyl)-9-(3-chloro-4-iodobenzylidene)-7-azatricyclo[4.3.1.0(3,7)]decane, 1, and (1S,3S,6R,10S)-(Z)-9-(3-chloro-4-iodobenzylidene)-7-azatricyclo[4.3.1.0(3,7)]decane-10-carboxylic acid methyl ester, 2, have been shown to be potent and selective serotonin transporter (SERT) ligands. They possess nanomolar affinity for the SERT (Ki = 0.06 nM and 1.8 nM respectively) and are suitable for radiolabelling using iodine-123. In the present study we prepared [(123)I]1 and [(123)I]2 from the appropriate tributylstannane precursors using acidic media with chloramine-T as the oxidising agent. The radiochemical yield obtained for [(123)I]1 varied between 50-60% while for [(123)I]2 the range was 65-80%. Both radioligands were obtained with radiochemical purity > 97% and specific activity estimated to be > 185 GBq/micromol. The biodistribution of [(123)I]1 demonstrated low degree of brain penetration at 5 min (0.14%ID/g) with a homogeneous distribution. The radioactivity cleared quickly from all brain regions with no preferential localization. In comparison, [(123)I]2 demonstrated on average a higher brain uptake at 5 min (0.5%ID/g). However the distribution of radioactivity was homogeneous and cleared to levels similar to [(123)I]1 at 1 hr post-injection. Pre-administration of citalopram failed to show any significant inhibition of [(123)I]2 uptake in the rat brain. The high lipophilicity of 1 and 2 (HPLC-derived log P(7.4) values of 6.41 and 4.25 respectively) and in vivo metabolism, seen by high thyroid uptake would explain the absence of any specific binding observed in the rat brain. In view of these results [(123)I]1 and [(123)I]2 do not appear to be suitable radioligands for in vivo studies of the SERT.


Journal of Labelled Compounds and Radiopharmaceuticals | 2000

Radiosynthesis of bromine-76 and iodine-123 labelled enantiomers of A-69024 : Radioligands for dopamine D1 receptor studies using PET and SPECT

Michael Kassiou; Christian Loc'h; Andrew Katsifis; Vahan Papazian; Filomena Mattner; Branko Dikic; Bernard Maziere

The racemic dopamine D1 receptor antagonist A-69024 was labelled with bromine-76 for studies using PET and with iodine-123 for SPECT. [76Br]A-69024 was prepared via electrophilic bromodestannylation with NH476Br. The use of chloramine-T in acid media resulted in radiochemical yields of 70–80%. The racemic radioligand was purified by semi-preparative C-18 reverse-phase HPLC while the (+) and (−) enantiomers were separated and isolated using chiral HPLC. Average specific activities of 11 GBq/μmol were obtained. In an analogous manner, 2-[123I]A-69024 was prepared via electrophilic iododestannylation with Na123I resulting in rediochemical yields of 65–70%. Chiral HPLC gave the (+) and (−) enantiomers with specific activities of >74 GBq/μmol. The chemical and enantiomeric purity of each enantiomer of both radioligands assessed by chiral HPLC was >98%. Radiochemical purities measured by radio-TLC were >98%. The average time of synthesis for both preparations was 70 minutes. Copyright


Archive | 1999

IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS

Andrew Katsifis; Filomena Mattner; Karin Mardon; Vahan Papazian; Branko Dikic


Journal of Labelled Compounds and Radiopharmaceuticals | 2005

The preparation of 123/125I-clioquinol for the study of Aβ protein in Alzheimer's disease

Vahan Papazian; Terri Jackson; Tien Q. Pham; X. Liu; Ivan Greguric; Christian Loc'h; Christopher C. Rowe; Victor L. Villemagne; Colin L. Masters; Andrew Katsifis


Applied Radiation and Isotopes | 2006

A rapid and efficient preparation of [123I]radiopharmaceuticals using a small HPLC (Rocket) column.

Andrew Katsifis; Vahan Papazian; Timothy Jackson; Christian Loc’h


Radiochimica Acta | 2000

Synthesis of substituted [ 123 I]imidazo[1,2-α]pyridines as potential probes for the study of the peripheral benzodiazepine receptors using SPECT

Andrew Katsifis; Filomena Mattner; Branko Dikic; Vahan Papazian


Archive | 1999

Imidazo[1,2-a]pyridine als mittel zum binden des peripheralen benzodiazepin-rezeptors Imidazo [1,2-a] pyridine as a means for binding the peripheral benzodiazepine receptor

Andrew Katsifis; Filomena Mattner; Karin Mardon; Vahan Papazian; Branko Dikic


Archive | 1999

Imidazo [1,2-a] pyridine as a medium to bind the peripheral benzodiazepine receptor

Andrew Katsifis; Filomena Mattner; Karin Mardon; Vahan Papazian; Branko Dikic

Collaboration


Dive into the Vahan Papazian's collaboration.

Top Co-Authors

Avatar

Andrew Katsifis

Royal Prince Alfred Hospital

View shared research outputs
Top Co-Authors

Avatar

Filomena Mattner

Australian Nuclear Science and Technology Organisation

View shared research outputs
Top Co-Authors

Avatar

Branko Dikic

Australian Nuclear Science and Technology Organisation

View shared research outputs
Top Co-Authors

Avatar

Karin Mardon

Australian Nuclear Science and Technology Organisation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christian Loc’h

Australian Nuclear Science and Technology Organisation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ivan Greguric

Australian Nuclear Science and Technology Organisation

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge